Delivery Order SPE2DR25D3103-SPE2DR26F9K29
- Not listed
- The Defense Logistics Agency awarded a $4,657.95 delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Duloxetine HCL DR 30 mg on December 5, 2025, with an ultimate completion date of December 8, 2025. This contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. This delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $3,022.92 for 1,000 capsules of Duloxetine HCL DR 60 mg. The award, issued on August 20, 2025, with an ultimate completion date of August 21, 2025, carries a firm fixed price and was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,543.89 to AmerisourceBergen Drug Corp for the supply of Duloxetine HCL DR 20 mg capsules (1,000 units). The contract employs firm fixed price pricing with no set-aside designation and has an ultimate completion date of December 12, 2025. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $39,410.23 to AmerisourceBergen Drug Corp for the supply of 1,000 units of Duloxetine HCL DR 30 mg capsules. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 25, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed and delivered from the vendor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Duloxetine HCL DR 40 mg capsules (30-count unit) with a ceiling value of $1,487.88. This non-set-aside, firm fixed-price delivery order is scheduled for completion by October 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of 1,000 units of Duloxetine HCl DR 30 mg capsules at a firm fixed price of $1,859.10. This is a non-set-aside competitive award with an ultimate completion date of November 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $3,470.07 to AmerisourceBergen Drug Corp for the supply of 1,000 units of Duloxetine HCl DR 20 mg capsules. This order, issued on October 30, 2025, with an ultimate completion date of October 31, 2025, represents a firm fixed-price delivery against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,520.41 for 1,000 capsules of Duloxetine HCL DR 30 mg on November 25, 2025, with completion scheduled for November 26, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the prime contractor for pharmaceutical supply to federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,280.14 to AmerisourceBergen Drug Corp for Duloxetine HCL DR 60 mg capsules (30-count packaging) on December 4, 2025, with an ultimate completion date of December 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,112.27 to AmerisourceBergen Drug Corp for the supply of Duloxetine HCL (delayed-release) 20 mg capsules in quantities of 1,000 units. The contract is firm fixed price with no set-aside designation and was awarded on November 4, 2025, with an ultimate completion date of November 5, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9K29Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency valued at $2,393.10 for 1,000 capsules of Duloxetine HCL DR 20 mg. Awarded on December 1, 2025, with a completion date of December 2, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract is performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, and represents a child order under a larger federal contract vehicle. This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Duloxetine HCL is a commonly prescribed serotonin-norepinephrine reuptake inhibitor used for pain management and depression treatment, aligning with the Defense Logistics Agency's critical need to supply medications across the federal medical supply chain serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 11/30/25 |